𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Assessing the efficacy of cholinesterase inhibitor drugs

✍ Scribed by Paul Hopper; Carol Trotter

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
35 KB
Volume
18
Category
Article
ISSN
0885-6230

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cholinesterase inhibitors in the treatme
Cholinesterase inhibitors in the treatment of dementia
✍ Maria Luisa Margallo-Lana; Clive Ballard; Chris Morris; David Kay; Stephen Tyrer πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 36 KB

fact may be ascribed to a primarily biological origin of the disease, not correlated with other possible causative events (e.g. chronic somatic diseases). On the other hand, in patients with reactive depressive symptoms a higher prevalence of somatic dysfunction (e.g. number of diseases, Charlson In

Efficacy of cognitive rehabilitation in
Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors
✍ Luca Rozzini; Daniela Costardi; Barbara Vicini Chilovi; Simone Franzoni; Marco T πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 86 KB πŸ‘ 1 views

## Abstract ## Background Individuals who have Mild Cognitive Impairment (MCI) may be in a transitional stage between aging and Alzheimer's disease (AD). The high rate of conversion from MCI to AD makes early treatment an important clinical issue. Recent evidence suggests that cognitive training i

A framework establishing clear decision
A framework establishing clear decision criteria for the assessment of drug efficacy
✍ William J. Huster; Gregory G. Enas πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 88 KB πŸ‘ 2 views

Much has been published on various aspects of data analysis and reporting from clinical trials within the biopharmaceutical environment. This ranges from regulatory guidelines on the format and content of registration dossiers to recommendations on data presentation and the statistical methodologies